• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

校正移行区体积和游离与总前列腺特异抗原比值后前列腺体积对前列腺特异抗原水平的影响:一项前瞻性研究。

The influence of prostate volume on the prostate-specific antigen (PSA) level adjusted for the transition zone volume and free-to-total PSA ratio: a prospective study.

作者信息

Moon D G, Yu J W, Lee J G, Kim J J, Koh S K, Cheon J

机构信息

Department of Urology, Korea University College of Medicine, Seoul, Korea.

出版信息

BJU Int. 2000 Oct;86(6):670-4. doi: 10.1046/j.1464-410x.2000.00838.x.

DOI:10.1046/j.1464-410x.2000.00838.x
PMID:11069374
Abstract

OBJECTIVES

To evaluate the influence of prostate volume on the prostate-specific antigen (PSA) level adjusted for the transition zone volume (PSAT) and free-to-total PSA ratio (f/tPSA) in detecting prostate cancer in men with intermediate PSA levels of 4.1-10.0 ng/mL.

PATIENTS AND METHODS

From March 1997 to June 1999, the f/tPSA and PSAT were measured in 105 patients who underwent ultrasound-guided systemic biopsies and had a PSA level of 4.1-10.0 ng/mL, with an apparently normal prostate on a digital rectal examination. The PSAT and f/tPSA were evaluated in all patients and in subgroups of patients with small (< 40 mL) or large (> or = 40 mL) prostates, using receiver operating characteristic (ROC) curves.

RESULTS

Total prostate volume was highly correlated with transition zone volume in all patients and in both subgroups (P < 0.001). In all 105 patients, PSAT had a sensitivity of 82% and its use would have avoided the largest number of unnecessary biopsies (87% specificity) at a threshold value of 0.35 ng. In men with small prostates f/tPSA and PSAT had a high sensitivity and specificity, at threshold values of 0.12 and 0.35 ng, respectively. In large prostates the PSAT was superior to f/tPSA in detecting prostate cancer.

CONCLUSIONS

These results suggest that both f/tPSA and PSAT are useful in detecting prostate cancer in men with small prostates, while PSAT is superior to f/tPSA in detecting prostate cancer in men with large prostates.

摘要

目的

评估前列腺体积对经前列腺移行区体积校正的前列腺特异性抗原(PSAT)水平及游离前列腺特异性抗原与总前列腺特异性抗原比值(f/tPSA)在检测前列腺特异抗原水平处于4.1 - 10.0 ng/mL之间男性前列腺癌中的影响。

患者与方法

1997年3月至1999年6月,对105例行超声引导下系统性活检且前列腺特异抗原水平为4.1 - 10.0 ng/mL、直肠指检前列腺外观正常的患者测定f/tPSA和PSAT。使用受试者操作特征(ROC)曲线对所有患者以及前列腺体积小(< 40 mL)或大(≥ 40 mL)的患者亚组中的PSAT和f/tPSA进行评估。

结果

在所有患者及两个亚组中,前列腺总体积与移行区体积高度相关(P < 0.001)。在所有105例患者中,PSAT的敏感性为82%,在阈值为0.35 ng时使用PSAT可避免最多数量的不必要活检(特异性为87%)。在前列腺体积小的男性中,f/tPSA和PSAT分别在阈值为0.12和0.35 ng时具有高敏感性和特异性。在前列腺体积大的男性中,PSAT在检测前列腺癌方面优于f/tPSA。

结论

这些结果表明,f/tPSA和PSAT在检测前列腺体积小的男性前列腺癌中均有用,而在检测前列腺体积大的男性前列腺癌中,PSAT优于f/tPSA。

相似文献

1
The influence of prostate volume on the prostate-specific antigen (PSA) level adjusted for the transition zone volume and free-to-total PSA ratio: a prospective study.校正移行区体积和游离与总前列腺特异抗原比值后前列腺体积对前列腺特异抗原水平的影响:一项前瞻性研究。
BJU Int. 2000 Oct;86(6):670-4. doi: 10.1046/j.1464-410x.2000.00838.x.
2
Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.复合前列腺特异性抗原、总前列腺特异性抗原及移行区的复合前列腺特异性抗原密度、复合/总前列腺特异性抗原比值、游离/总前列腺特异性抗原比值、总前列腺特异性抗原及移行区前列腺特异性抗原密度:欧洲前瞻性多中心试验结果
Urology. 2002 Oct;60(4 Suppl 1):4-9. doi: 10.1016/s0090-4295(02)01896-4.
3
Prostate specific antigen (PSA) value adjusted for transition zone volume and free PSA (gamma-seminoprotein)/PSA ratio in the diagnosis of prostate cancer in patients with intermediate PSA levels.在中间前列腺特异性抗原(PSA)水平患者的前列腺癌诊断中,根据移行区体积和游离PSA(γ-精浆蛋白)/PSA比值调整PSA值。
Br J Urol. 1998 Aug;82(2):224-30. doi: 10.1046/j.1464-410x.1998.00696.x.
4
Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together.使用基于总前列腺特异性抗原的参数对前列腺癌进行诊断的方法。
Ann Clin Lab Sci. 2002 Winter;32(1):22-30.
5
The significance of the free-to-complexed prostate-specific antigen (PSA) ratio in prostate cancer detection in patients with a PSA level of 4.1-10.0 ng/mL.游离态与复合态前列腺特异性抗原(PSA)比值在前列腺特异抗原水平为4.1 - 10.0 ng/mL的患者前列腺癌检测中的意义。
BJU Int. 2000 Apr;85(6):708-14. doi: 10.1046/j.1464-410x.2000.00602.x.
6
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter.复合前列腺特异性抗原用于早期检测血清前列腺特异性抗原水平为2至4纳克/毫升男性的前列腺癌。
Urology. 2002 Oct;60(4 Suppl 1):31-5. doi: 10.1016/s0090-4295(02)01693-x.
7
Prostate specific antigen density of the transition zone for early detection of prostate cancer.用于早期检测前列腺癌的移行区前列腺特异性抗原密度
J Urol. 1998 Aug;160(2):411-8; discussion 418-9.
8
Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSA.复合前列腺特异性抗原(PSA)可减少总PSA在2.6 - 4.0 ng/mL范围内不必要的前列腺活检。
BJU Int. 2004 Jul;94(1):47-50. doi: 10.1111/j.1464-410X.2004.04899.x.
9
Prostate-specific antigen adjusted for the transition zone volume versus free-to-total prostate-specific antigen ratio in predicting prostate cancer.在预测前列腺癌方面,根据移行区体积调整的前列腺特异性抗原与游离前列腺特异性抗原与总前列腺特异性抗原比值的比较。
Int J Urol. 1999 Sep;6(9):455-62. doi: 10.1046/j.1442-2042.1999.00089.x.
10
Prediction of prostate cancer in extended-field biopsies of the prostate.前列腺扩大穿刺活检中前列腺癌的预测
BJU Int. 2004 Mar;93(4):516-21. doi: 10.1111/j.1464-410x.2003.04670.x.

引用本文的文献

1
Usefulness of Total PSA Value in Prostate Diseases Diagnosis.总前列腺特异抗原值在前列腺疾病诊断中的应用价值
Acta Inform Med. 2016 Jun;24(3):156-61. doi: 10.5455/aim.2016.24.156-161. Epub 2016 Jun 4.
2
Current usefulness of free/total PSA ratio in the diagnosis of prostate cancer at an early stage.游离/总前列腺特异抗原比值在早期前列腺癌诊断中的当前应用价值。
World J Urol. 2005 Sep;23(4):236-42. doi: 10.1007/s00345-005-0506-4. Epub 2005 Nov 8.